Two monks were traveling together and came to a river with a raging current. A young woman stood alongside the bank. She was afraid to cross, so she asked the monks if they would help.

The monks looked at each other, wondering what to do next. They had taken vows to never touch a woman.

Finally, one of the monks lifted the young woman and carried her across the river. When he returned, both monks continued their journey.

Hours went by without so much a word between them.

One of the monks could no longer remain silent. “As monks, we took a vow to never touch a woman, yet you carried the young lady across the river in your arms!” he said.

“I left the girl on the other side of the river, why are you still carrying her?” said the other.

--

--

Spot AI, a San Francisco-based video intelligence company, recently closed a $40M Series B funding round. This round brings total funding to $62M. The investment will accelerate Spot AI’s efforts to help businesses unleash valuable insights from their video data using Artificial Intelligence.

Surveillance camera growth has exploded since 2015, and today there are close to one billion security cameras installed world-wide.

The company was formed by engineers from Stanford, Cisco Meraki, and Samsara with a mission to create a safer world through video intelligence.

You can learn more here.

--

--

MoneyLion ($ML) acquired Even Financial, Inc. (Fund II). The acquisition opens up MoneyLion platform users to a network of over 400 financial firms and 500 channel partners who provide a wide-array of financial services and products.

Even revolutionized the customer experience for financial services recommendations through machine learning and a trusted user experience. The first phase of product integration is complete, with over 60 solutions providers from Even now available on MoneyLion’s Marketplace.

Even will operate as an independent subsidiary of MoneyLion, and Even’s current management team will continue to lead. You can learn more here.

--

--

AI Proteins has built the first platform for designing entirely synthetic proteins from scratch. De novo protein design is finally ready for commercial applications after spending a decade in academia. “With this technology, we will be able to bring next-generation therapeutics to the clinic faster,” said AI Proteins founder, President, and CSO Dr. Chris Bahl.

The $18.2M seed round was co-led by Cobro Ventures and Lightchain Capital, the company announced in a release.

‘De novo design’ allows engineers to design the proteins they want instead of editing existing natural proteins. AI Proteins does this with a novel approach for designing entirely new proteins using an AI-based platform; enabling the development of inexpensive, durable, specific proteins optimized for oral delivery.

--

--